In the BioHarmony Drug Report Database

"Preview" Icon

Trimetrexate glucuronate

Neutrexin (trimetrexate glucuronate) is a small molecule pharmaceutical. Trimetrexate glucuronate was first approved as Neutrexin on 1993-12-17. It is used to treat pneumocystis pneumonia in the USA. It is known to target dihydrofolate reductase.

 

Trade Name

 

Neutrexin
 

Common Name

 

trimetrexate glucuronate
 

ChEMBL ID

 

CHEMBL2218878
 

Indication

 

pneumocystis pneumonia
 

Drug Class

 

Antimetabolites (folic acid derivatives)

Image (chem structure or protein)

Trimetrexate glucuronate structure rendering